Cerca Articoli
Russia: President signs decree on additional information security measures
Russian President Vladimir Putin signed a decree “On additional measures to ensure the information security of the Russian Federation.” The document, published on the official portal of legal information on May 1, states that it should serve to “increase the stability and security of the functioning of the information resources of the Russian Federation.”
CNIL publishes a new White paper on payment data and means of payment
What are the data protection challenges when making a payment? In order to raise awareness of the public, support professionals and anticipate future transformations, CNIL has published a new White paper which now can be read in its English version: "When trust pays off: today's and tomorrow's means of payment methods facing the challenge of data protection".
A new strategic approach to health for the EU (2008-2013)
The present White Paper sets out a new Community health strategy until 2013, which is designed to confront the growing challenges to the health of Europe's citizens, such as population ageing, cross-border health threats or illnesses linked to unhealthy lifestyles. This strategy is also intended to strengthen, in a single strategic framework, Community cooperation in the areas in which the Member States cannot act alone, ensure that health is better understood at European level and worldwide, and secure a bigger role for health in all policies. To this end, the White Paper proposes four principles and three strategic objectives for the coming years.
Launch of .eu will start before the end of 2005
Check out our domain name: .eu is now in the internet root
MEDICINE: THE WEIGHT HORMONE CAN REGULATE OUR IMMUNE SYSTEM
A study carried out by the team of Immune Endocrinology of CNR from Naples, published on the Journal of Clinical Investigation, has underlined the key role played by leptine - a hormone regulating body weight - in the aetiology of serious autoimmune diseases such as experimental multiple sclerosis (experimental allergic encephalitis EAE) and autoimmune diabetes.
Phase II Study Results Show Up to 93% Reduction in New Gadolinium-Enhancing Lesions
CLINICAL STUDY RESULTS PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE SHOW PROMISING DATA ON ANTEGREN-® (natalizumab) IN THE TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS